Nexalin Technology (NXL) Earnings Date & Reports

Nexalin Technology Inc designs and develops neurostimulation products and bioelectronic medical technology to treat anxiety and insomnia without drugs or psychotherapy... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

NXL is expected to report earnings to fall 18.18% to -9 cents per share on December 02

Nexalin Technology NXL Stock Earnings Reports

Q3'26

Est.

$-0.09

Q2'26

Missed

by $0.01

Q1'26

Beat

by $0.01

Q4'25

Missed

by $0.01

Q3'25

Missed

by $0.01

The last earnings report on August 12 showed earnings per share of -10 cents, missing the estimate of -10 cents. With 513.39K shares outstanding, the current market capitalization sits at 3.54M.

View a ticker or compare two or three

NXL

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for NXL